Oxidation, Inflammation, and Aortic Valve Calcification. Peroxide Paves an Osteogenic Path**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 10, 2008, Pages 851-854

  Towler, Dwight A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

aortic valve calcification; osteogenic differentiation; oxidative stress

Indexed keywords

BETA CATENIN; CATALASE; FETUIN; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OSTEOPONTIN; PEROXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

AORTA VALVE CALCIFICATION; AORTA VALVE DISEASE; ARTERY CALCIFICATION; EDITORIAL; HUMAN; INFLAMMATION; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 49849083168     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.05.044     Document Type: Editorial

References (31)

1. Rajamannan N.M., Bonow R.O., and Rahimtoola S.H. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 4 (2007) 254-262
2. Katz R., Wong N.D., Kronmal R., et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113 (2006) 2113-2119
3. Abedin M., Tintut Y., and Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24 (2004) 1161-1170
4. Lehto S., Niskanen L., Suhonen M., Ronnemaa T., and Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16 (1996) 978-983
5. Shao J.S., Cai J., and Towler D.A. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26 (2006) 1423-1430
6. Burke A.P., Kolodgie F.D., Farb A., Weber D., and Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 105 (2002) 297-303
7. Ehara S., Kobayashi Y., Yoshiyama M., et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 110 (2004) 3424-3429
8. Aikawa E., Nahrendorf M., Figueiredo J.L., et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116 (2007) 2841-2850
9. Johnson R.C., Leopold J.A., and Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99 (2006) 1044-1059
10. Miller J.D., Chu Y., Brooks R.M., Richenbacher W.E., Peña-Silva R., and Heistad D.D. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 52 (2008) 843-850
11. Haurani M.J., and Pagano P.J. Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?. Cardiovasc Res 75 (2007) 679-689
12. Bedard K., and Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87 (2007) 245-313
13. Liu J., Ormsby A., Oja-Tebbe N., and Pagano P.J. Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy. Circ Res 95 (2004) 587-594
14. Dikalova A., Clempus R., Lassegue B., et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112 (2005) 2668-2676
15. Munzel T., Daiber A., Ullrich V., and Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25 (2005) 1551-1557
16. O'Brien K.D. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26 (2006) 1721-1728
17. Johnson M.L., and Rajamannan N. Diseases of Wnt signaling. Rev Endocr Metab Disord 7 (2006) 41-49
18. Tyson K.L., Reynolds J.L., McNair R., Zhang Q., Weissberg P.L., and Shanahan C.M. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23 (2003) 489-494
19. Al-Aly Z., Shao J.S., Lai C.F., et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol 27 (2007) 2589-2596
20. Shao J.S., Cheng S.L., Pingsterhaus J.M., Charlton-Kachigian N., Loewy A.P., and Towler D.A. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115 (2005) 1210-1220
21. Shao J.S., Aly Z.A., Lai C.F., et al. Vascular BMP Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci 1117 (2007) 40-50
22. Lai-Huang C.F., Shal J.S., Al-Aly Z., Cheng S.L., and Towler D.A. TNF-alpha dependent redox signals upregulate msx2 gene transcription via stress activated protein kinases in arterial myofibroblasts (abstr). J Bone Miner Res 22 (2007) T165
23. Funato Y., Michiue T., Asashima M., and Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol 8 (2006) 501-508
24. Byon C.H., Javed A., Dai Q., et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx-2 by AKT signaling. J Biol Chem 283 (2008) 15319-15327
25. Nemoto M., Nishimura R., Sasaki T., et al. Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc Diabetol 6 (2007) 1-7
26. Shanahan C.M. Inflammation ushers in calcification: a cycle of damage and protection?. Circulation 116 (2007) 2782-2785
27. Mohler III E.R., Gannon F., Reynolds C., Zimmerman R., Keane M.G., and Kaplan F.S. Bone formation and inflammation in cardiac valves. Circulation 103 (2001) 1522-1528
28. Cucoranu I., Clempus R., Dikalova A., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97 (2005) 900-907
29. Richardson J.A., Amantea C.M., Kianmahd B., et al. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway. J Cell Biochem 100 (2007) 1131-1145
30. Laird D.F., Mucalo M.R., and Yokogawa Y. Growth of calcium hydroxyapatite (Ca-HAp) on cholesterol and cholestanol crystals from a simulated body fluid: a possible insight into the pathological calcifications associated with atherosclerosis. J Colloid Interface Sci 295 (2006) 348-363
31. Scatena M., Liaw L., and Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27 (2007) 2302-2309